Active Surveillance In Intermediate-Risk Prostate Cancer

Posted on April 6, 2015 by "Coach" Israel Barken M.D.

Active Surveillance In Intermediate-Risk Prostate Cancer Called Into Question.
https://youtu.be/dBk3z2T9KwQ

Dr. Israel Barken brings info about higher risk of cancer specific mortality in the intermediate prostate cancer risk group. The study presentor at the GenitoUrinary Symposium 2015 was Dr. Andrew Loblaw. The study was conducted at the Sunnybrook Health Sciences Center. The risk of prostate cancer-specific death at 15 years was 3.75 times higher for intermediate risk patients compared to patients with low risk patients.

Source: ASCO POST March , 2015

This entry was posted in Active Surveillance, Treatments for Prostate Cancer and tagged , . Bookmark the permalink.

1 Response to Active Surveillance In Intermediate-Risk Prostate Cancer

  1. Bill Reeves says:
    April 11, 2015 at 11:05 am

    Thanks for your help, both personal and on e-mail.  Dr Bahn has declared me cancer free after 2 years   of watchful waiting, including 3  coloroscopies.There is no cancer ,  but evidence of BPH problems over 50 yrs.  Was scheduled for a biopsy by a local Urologist, but I did research , found you and Dr. Bahn , and have not had a biopsy.  Thanks again.                                                  Dr Bill Reeves